Name: TLSI Income Statement - Trisalus Life Sciences Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

TLSI - Trisalus Life Sciences, Inc.

USD | NASDAQ | Healthcare

TLSI Income Statement - Trisalus Life Sciences Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21
Revenues
Revenues	8.9	13.2	11.6	11.2	9.2	8.3	7.3	7.4	6.5	5.7	5.2	4.6	3.0	-	3.9	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues
Revenues	44.9	45.2	29.4	18.5	12.4	-
Cost of Revenue	6.7	7.0	4.1	2.6	2.3	-
Gross Profit	38.2	38.2	25.3	15.9	10.1	-
Operating Expenses
Research & Development	15.2	15.0	17.7	29.8	21.4	-
Selling General & Administrative	-	-	-	-	-	-
Operating Income
Operating Income	(28.0)	(26.9)	(36.2)	(54.5)	(36.4)	(3.0)
Non-Operating
Interest Income	0.6	0.6	0.4	0.4	0.2	0.1
Interest Expense	5.8	5.5	3.1	0.0	0.0	-
Income From Equity Investments
Tax & Net
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	(27.3)	(39.2)	(30.0)	(59.4)	5.5	4.8
Net Income From Discontinued Ops
Per Share
EPS Basic	(1.11)	(1.84)	(1.31)	(6.77)	(161.55)	-
EPS Diluted	(1.09)	(1.84)	(1.31)	(6.77)	(161.55)	-
Shares Basic
Supplementary Data
EBITDA	-	(26.3)	(35.4)	(53.8)	(36.0)	-
EBIT	(28.0)	(26.9)	(36.2)	(54.5)	(36.4)	(3.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Income
Operating Income	(8.4)	(3.3)	(9.0)	(7.3)	(7.3)	(7.6)	(8.7)	(8.2)	(11.7)	(14.3)	(18.6)	(11.4)	(10.1)	(27.4)	(8.1)	(0.3)	(0.7)	(1.1)	(0.8)	(0.8)	(0.3)

Tax & Net
Income Tax Expense	0.0	0.0	0.0	(0.0)	0.0	(0.0)	(0.0)	0.0	0.0	0.0	0.0	0.0	(0.0)	(0.0)	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	1.5	(9.8)	(10.8)	(8.3)	(10.4)	(10.1)	(2.4)	(4.3)	(13.2)	(43.5)	(1.4)	(14.0)	(0.4)	19.5	(8.1)	(8.7)	2.8
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	1.5	(9.8)	(10.8)	(8.3)	(10.4)	(10.1)	(2.4)	(4.3)	(13.2)	(43.5)	(1.4)	(14.0)	(0.4)	19.5	(8.1)	(8.7)	2.8
Net Income Attributable To Parent	1.5	(9.8)	(10.8)	(8.3)	(10.4)	(10.1)	(2.4)	(4.3)	(13.2)	(35.6)	(1.4)	(14.0)	(8.3)	(22.5)	(8.1)	(8.7)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	0.0	(1.4)	0.0	0.7	0.7	0.8	0.8	0.8	0.8	0.8	0.5	0.0	0.0	-	0.0	-	-
Net Income To Common Shareholders	1.5	(8.3)	(41.3)	(9.0)	(11.1)	(10.9)	(3.2)	(5.1)	(14.0)	(36.5)	(1.9)	(16.0)	(9.2)	(25.4)	(8.1)

Per Share
EPS Basic	0.03	-	(0.96)	(0.27)	(0.39)	-	(0.12)	(0.21)	(0.60)	-	(0.14)	(35.84)	(0.57)	-	(25.95)	-	-	-	-	-	-
EPS Diluted	0.03	-	(0.96)	(0.27)	(0.39)	-	(0.12)	(0.21)	(0.60)	-	(0.14)	(35.84)	(0.57)	-	(25.95)	-	-	-
Shares Basic	51.5	-	43.1	32.9	28.5	-	26.5	23.9	23.3	-	13.2	0.4	16.2	-	0.3	-	-	-
Shares Diluted	52.3	-	43.1	32.9	28.5	-	26.5	23.9	23.3	-	13.2	0.4	16.2	-	0.3	-	-	-

Supplementary Data
EBITDA	(8.3)	-	-	-	(7.2)	-	-	-	(11.5)	-	-	-	(9.9)	-	-	-	-	-	-	-	-
EBIT	(8.4)	(3.3)	(9.0)	(7.3)	(7.3)	(7.6)	(8.7)	(8.2)	(11.7)	(14.3)	(18.6)	(11.4)	(10.1)	(27.4)	(8.1)	(0.3)	(0.7)	(1.1)	(0.8)

Non-Operating
Interest Income	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	(0.2)	0.0	0.3	0.1	0.0	0.0	0.0	0.0
Interest Expense	1.4	1.5	1.5	1.4	1.2	1.1	1.1	0.9	0.0	0.0	0.0	0.0	0.0	-	0.0	-	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(0.1)	(0.1)	(0.1)	(0.0)	(0.3)	(0.1)	(0.0)	(0.0)	(0.2)	(1.3)	(0.0)	0.5	0.4	1.4	1.3	2.7	3.5
Pre-Tax Income	1.5	(9.8)	(10.8)	(8.3)	(10.4)	(10.1)	(2.4)	(4.3)	(13.2)	(35.7)	(1.4)	(14.0)	(8.3)	(44.3)	(8.1)	2.4